ArticlePloS one2017

Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.

Nuria Maicas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.